HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inducible nitric oxide synthase inhibition of weibel-palade body release in cardiac transplant rejection.

AbstractBACKGROUND:
Inducible nitric oxide synthase (iNOS, or NOS2) reduces the severity of accelerated graft arteriosclerosis (AGA) in transplanted organs, although the precise mechanism is unclear.
METHODS AND RESULTS:
We transplanted wild-type murine hearts into either wild-type or NOS2-null recipient mice; we then measured cardiac allograft survival and analyzed tissue sections by immunohistochemistry. We have confirmed that NOS2 increases cardiac allograft survival. We now show that there is less inflammation of cardiac allografts in wild-type hosts than in NOS2-null hosts. Furthermore, staining for von Willebrand factor reveals that the presence of NOS2 is correlated with the presence of Weibel-Palade bodies inside endothelial cells, whereas the absence of NOS2 is correlated with the release of Weibel-Palade bodies.
CONCLUSIONS:
Weibel-Palade bodies contain mediators that promote thrombosis and inflammation. Therefore, nitric oxide (NO) may stabilize the vessel wall and prevent endothelial activation in part by inhibiting the release of the contents of Weibel-Palade bodies. Prevention of Weibel-Palade body release might be a mechanism by which NO protects the vessel wall from inflammatory disorders such as atherosclerosis or graft arteriosclerosis.
AuthorsZ Qian, R Gelzer-Bell, S X Yang Sx, W Cao, T Ohnishi, B A Wasowska, R H Hruban, E R Rodriguez, W M Baldwin 3rd, C J Lowenstein
JournalCirculation (Circulation) Vol. 104 Issue 19 Pg. 2369-75 (Nov 06 2001) ISSN: 1524-4539 [Electronic] United States
PMID11696480 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • von Willebrand Factor
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • Nos2 protein, mouse
Topics
  • Animals
  • Disease Progression
  • Endothelium, Vascular (metabolism, pathology, ultrastructure)
  • Fluorescent Antibody Technique
  • Graft Rejection (genetics, immunology, pathology)
  • Graft Survival (genetics, immunology)
  • Heart Transplantation (immunology)
  • Immunohistochemistry
  • Inflammation (enzymology, genetics, pathology)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Mutant Strains
  • Microscopy, Electron
  • Nitric Oxide Synthase (genetics, metabolism)
  • Nitric Oxide Synthase Type II
  • Transplantation, Homologous (immunology, pathology)
  • Weibel-Palade Bodies (metabolism, pathology, ultrastructure)
  • von Willebrand Factor (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: